Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health Inc (NY: HIMS )

19.32 -1.53 (-7.34%)
Official Closing Price Updated: 7:00 PM EST, Nov 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health Inc

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Why Hims & Hers Health Stock Soared Today
Profitability could come sooner than investors expected. 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers 
Via Benzinga
Analyst Ratings for Hims & Hers Health
Within the last quarter, Hims & Hers Health (NYSE:HIMS) has observed the following analyst ratings: 
Via Benzinga
Party City (PRTY) Stock Plunges After a Spooky Halloween
Party City (PRTY) stock isn't doing so hot on Tuesday after posting results from its Halloween quarter and 2022 cutting guidance. 
Via InvestorPlace
Why Is Hims & Hers (HIMS) Stock Up 24% Today?
Hims & Hers (HIMS) stock is climbing higher on Tuesday after reporting results for the third quarter of 2022 and increasing guidance. 
Via InvestorPlace
SolarEdge Technologies, LivePerson, TaskUs And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
This Stock Could 10X in 5 Years
An assessment of the company's prospects reveal an ecouraging outlook. 
Via The Motley Fool
4 Analysts Have This to Say About Hims & Hers Health
  Within the last quarter, Hims & Hers Health (NYSE:HIMS) has observed the following analyst ratings: 
Via Benzinga
Why TaskUs Shares Are Trading Higher By 37%? Here Are 77 Stocks Moving In Tuesday's Mid-Day Session
Gainers IceCure Medical Ltd (NASDAQ: ICCM) shares jumped 39.4% to $1.4529 after the company announced a payment assignment from the Centers for Medicare & Medicaid Services for the ProSense breast... 
Via Benzinga
Where Hims & Hers Health Stands With Analysts
Analysts have provided the following ratings for Hims & Hers Health (NYSE:HIMS) within the last quarter: 
Via Benzinga
Hims & Hers Health: Q2 Earnings Insights
  Hims & Hers Health (NYSE:HIMS) reported its Q2 earnings results on Monday, August 8, 2022 at 04:15 PM. Here's what investors need to know about the announcement. 
Via Benzinga
SVB Securities Sees 26% Downside In This Telehealth Platform
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 8, 2022
Upgrades 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers NeuroBo Pharmaceuticals (NASDAQ:NRBO) shares rose 49.1% to $3.22 during Tuesday's pre-market session. The company's market cap stands at $2.8 million. 
Via Benzinga
Why TripAdvisor Shares Are Trading Sharply Lower; Here Are 29 Stocks Moving Premarket
Gainers 
Via Benzinga
Hims & Hers Health, Inc. Reports Third Quarter 2022 Financial Results and Raises Full Year 2022 Outlook; Platform Demand and Financial Outperformance Driving Expected Adjusted EBITDA Profitability Beginning in Q4 2022
From Hims & Hers Health, Inc.
Via Business Wire
Earnings Preview For Hims & Hers Health
Hims & Hers Health (NYSE:HIMS) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Hims & Hers... 
Via Benzinga
Hims & Hers to Announce Third Quarter 2022 Earnings on November 7, 2022
From Hims & Hers Health, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022
Upgrades 
Via Benzinga
What 4 Analyst Ratings Have To Say About Hims & Hers Health
Over the past 3 months, 4 analysts have published their opinion on Hims & Hers Health (NYSE:HIMS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Hims & Hers appoints Chief Communications Officer & VP of Fulfillment Operations
From Hims & Hers Health, Inc.
Via Business Wire
Now More Than Ever Americans Are Open To Exploring Their Sexuality, Hims & Hers’ Nationwide Survey Uncovers The Realities Of Sex In America Today
From Hims & Hers Health, Inc.
Via Business Wire
What 4 Analyst Ratings Have To Say About Hims & Hers Health
Over the past 3 months, 4 analysts have published their opinion on Hims & Hers Health (NYSE:HIMS) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2022
Upgrades 
Via Benzinga
Hims & Hers Launches New Android Apps
From Hims & Hers Health, Inc.
Via Business Wire
Hims & Hers Health's Return on Invested Capital Overview
Benzinga Pro data, Hims & Hers Health (NYSE:HIMS) reported Q2 sales of $113.56 million. Earnings fell to a loss of $19.68 million, resulting in a 21.09% decrease from last quarter. 
Via Benzinga
What Is Going on With Teladoc (TDOC) Stock Today?
With Amazon dropping out of the telehealth business, Teladoc Health moved higher though TDOC stock may struggle longer term. 
Via InvestorPlace
Hims & Hers Health, Inc. Reports Second Quarter 2022 Financial Results and Raises Full Year 2022 Outlook
From Hims & Hers Health, Inc.
Via Business Wire
Earnings Preview For Hims & Hers Health
Hims & Hers Health (NYSE:HIMS) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that Hims & Hers... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.